This inventor holds 1 USPTO granted patent. Top assignee: Emerald Therapeutics, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kyla N Velaer: Innovator in Nucleic Acid Preparation Technologies
Introduction
Kyla N Velaer is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of biotechnology, particularly in the automated preparation of nucleic acids. Her innovative work has the potential to enhance various applications in genetic research and therapeutic development.
Latest Patents
Kyla holds a patent for "Systems and methods for automated preparation of nucleic acids." This patent describes a fabrication process that produces, anneals, and conjugates nucleic acid molecules using multiple instruments under the guidance of computer programs. The process involves synthesizing nucleic acids and peptide nucleic acids on solid supports, measuring sample volumes and concentrations, and employing chromatography to achieve single-base resolution for the products. This innovative approach streamlines the preparation of biomolecules, making it more efficient and precise.
Career Highlights
Kyla is currently employed at Emerald Therapeutics, Inc., where she continues to advance her research in nucleic acid technologies. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology. With her expertise, she contributes to the development of cutting-edge solutions that address complex challenges in genetic research.
Collaborations
Kyla collaborates with talented professionals in her field, including her coworkers Bradley M Bond and Eric Shyr. These collaborations foster a dynamic environment for innovation and knowledge sharing, further enhancing the impact of their collective work.
Conclusion
Kyla N Velaer is a trailblazer in the field of nucleic acid preparation technologies. Her contributions through her patent and work at Emerald Therapeutics, Inc. exemplify her dedication to advancing biotechnology. Her innovative spirit and collaborative efforts position her as a key figure in the ongoing evolution of genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile